Latest filing published 13 May 2015 for CoLucid Pharmaceuticals, Inc., €8,810.
Insider track record
No signal scores available.
Nadia Rupniak: trading record in brief
Nadia Rupniak discloses dealings in CoLucid Pharmaceuticals, Inc. to SEC (Form 4). Altogether 4 filings, all relating to 13 May 2015.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 13 May 2015 with an option exercise (€8,810) in CoLucid Pharmaceuticals, Inc. Publication is fast: at least half of the trades appear on SEC (Form 4) on the same day. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Nadia Rupniak
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,457 shares@ US$4.07Common StockSEC:0000911916-15-000191:0
- 5,541 shares@ US$5.09Common StockSEC:0000911916-15-000191:2
- 3,690 shares@ US$5.09Common StockSEC:0000911916-15-000191:3
3 of 3 declarations